New Alzheimer's drug breakthrough in the UK Featured
rucially they also found that after six months of the treatment, patients stopped deteriorating compared with those taking a placebo, suggesting that their dementia had been halted.
In the trial, which was reported in the journal Nature, scientists tested varying levels of the drug over a year, as well as giving one group a placebo. They found that more amyloid was removed as the dose increased. Brain scans of those given the highest dose shown virtually no amyloid left at all.
The drug is likely to be most effective for patients in the very earliest stages of Alzheimer’s disease, or those who have not yet begun to show symptoms. Several universities are working on early blood tests for dementia which could pick the disease up a decade or more before the first physical signs appear.
Dementia experts and charities said that the breakthrough offered real hope for the future treatment of Alzheimer’s disease
Latest from claude mills
Leave a comment
Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.